NeoPrediX AG

A recent study in BMJ Paediatrics Open sheds light on the challenges of managing neonatal jaundice, especially in areas with limited healthcare resources. The article highlights that “timely recognition of clinically significant hyperbilirubinemia is crucial” to prevent severe complications, yet high costs and logistical barriers limit access to early detection tools. 𝗔𝘁 𝗡𝗲𝗼𝗣𝗿𝗲𝗱𝗶𝗫, 𝘄𝗲’𝗿𝗲 𝗰𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝘀𝗼𝗹𝘃𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗶𝘀𝘀𝘂𝗲. Our 𝗷𝗮𝘂𝗻𝗱𝗶𝗰𝗲 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝘁𝗼𝗼𝗹 leverages predictive analytics to provide early, reliable risk assessments, helping clinicians make proactive decisions that reduce unnecessary treatments and prioritize high-risk cases. By making jaundice screening more accessible, we aim to close the gap. Let’s continue to push for innovations that ensure every baby gets the healthy start they deserve! See the article by Shahryar Mir 𝗕𝗲𝗿𝘁𝗵𝗲 𝘃𝗮𝗻 𝗱𝗲𝗿 𝗚𝗲𝗲𝘀𝘁 Jasper Been  https://lnkd.in/eMnBuCDB #NeoPrediX #JaundiceManagement #MaternalHealth #NeonatalCare

Don’t miss our CEO Thorsten Waloschek’s key takeaways and reflections on the #HLTH conference. It sounds like it was an incredible event with exciting insights for the future of healthcare!

𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? 💡 Women with preeclampsia are at 𝗱𝗼𝘂𝗯𝗹𝗲 𝘁𝗵𝗲 𝗿𝗶𝘀𝗸 𝗼𝗳 𝗵𝗲𝗮𝗿𝘁 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗮𝗻𝗱 𝘀𝘁𝗿𝗼𝗸𝗲 later in life. Preeclampsia isn’t just a pregnancy complication—it can have lasting effects on a woman’s health. At NeoPrediX, we’re working on predictive tools to help identify this risk early, providing mothers with the care and information they need to protect their long-term health. #PreeclampsiaAwareness #HeartHealth #MaternalHealth #NeoPrediX

Our CEO, Thorsten Waloschek, will be attending 𝗛𝗟𝗧𝗛 𝟮𝟬𝟮𝟰  in Las Vegas, from October 20 - 23. We’re thrilled to join some of the brightest minds in healthcare and innovation to discuss the future of predictive analytics in 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗮𝗻𝗱 𝗻𝗲𝗼𝗻𝗮𝘁𝗮𝗹 𝗰𝗮𝗿𝗲. If you’ll be at HLTH and would like to meet with Thorsten to explore how NeoPrediX is transforming maternal and neonatal outcomes with our cutting-edge predictive algorithms, please reach out! Let’s connect and explore new possibilities in healthcare together. #HLTH2024 #PredictiveAnalytics #MaternalHealth #NeonatalCare #HealthcareInnovation #NeoPrediX #TechInHealthcare

 𝗔 𝗛𝗲𝗮𝗿𝘁𝗯𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗟𝗼𝘀𝘀 𝗧𝗵𝗮𝘁 𝗦𝗵𝗼𝘂𝗹𝗱 𝗡𝗲𝘃𝗲𝗿 𝗛𝗮𝗽𝗽𝗲𝗻 💔 We are deeply saddened by the recent story of 𝗦𝗮𝗿𝗮 𝗦𝗲𝘄𝗮𝗹𝗱, a mother who tragically lost her life due to complications from preeclampsia shortly after giving birth to twins. Despite reassurances that her condition was stable, Sara’s health deteriorated rapidly, leaving behind her newborns and a devastated family. Sara’s story is one of many that highlight the devastating effects of preeclampsia, a leading cause of maternal mortality worldwide, affecting millions of women each year. At 𝗡𝗲𝗼𝗣𝗿𝗲𝗱𝗶𝗫, we are committed to preventing tragedies like Sara’s. We are developing innovative 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝘁𝗼𝗼𝗹𝘀 to detect early signs of preeclampsia, giving healthcare providers more time to intervene and save lives. Preeclampsia can be silent and fast-acting, which is why 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 is critical. Our mission is to ensure no more families experience such a heartbreaking loss by equipping clinicians with the insights they need to act sooner. Sara’s story is a reminder of why our work matters. We honor her memory by continuing to fight for a future where no mother or child is lost to this condition. Together, we can make a difference. #MaternalHealth #PreeclampsiaAwareness #NeonatalCare #PredictiveAnalytics #NeoPrediX #HealthcareInnovation

"The rate of hypertensive disorders in pregnancy, including preeclampsia, has almost doubled over the past decade, rising from 4.4% in 2010 to 9.4% in 2021. This increase highlights the need for innovative, preventive healthcare solutions to address these risks, particularly in underserved populations." – JAMA, 2024 (Contemporary OB/GYN) At NeoPrediX, we believe that technology can help prevent tragic outcomes by providing clinicians with predictive tools to identify and manage high-risk pregnancies earlier. As maternal health challenges grow, especially with conditions like preeclampsia, the time for change is now. Read to learn more about these rising trends in pregnancy-related hypertensive disorders and ask us how NeoPrediX is stepping up to protect mothers and babies. #Preeclampsia #MaternalHealth #HealthcareInnovation #PredictiveAnalytics #NeonatalCare Celeste Krewson Rodney McLaren Mariam Ayyash Majid Shaman, MD, FACOG Huda Al-Kouatly Jill Jin

We are thrilled to announce that NeoPrediX AG has been selected as a finalist for the Health Tech Challengers in December! 🎉 NeoPrediX will be pitching alongside some of the most innovative startups in women’s health, all working to address unique healthcare needs. We’re proud to be part of this incredible lineup, driving change in healthcare with our groundbreaking solutions for maternal and neonatal care. A huge shoutout to all the finalists: 80 Beats Medical DeepLook Medical Hormony ® (Prelude Health) Nabsolute Impli Innitius LoOoP by Neuraura Prolevi Bio The Blue Box Biomedical Solutions Join us at the event and cheer us on as we showcase how NeoPrediX is advancing the future of healthcare! Get your tickets and witness the future of women’s health tech ! 🎟 healthtechforward.com #HealthTechChallengers #WomensHealth #MaternalCare #NeonatalInnovation #HealthTech #HealthcareTransformation #Innovation #NeoPrediX

At NeoPrediX, we're exploring the future of 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝗶𝗻 𝗺𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗮𝗻𝗱 𝗻𝗲𝗼𝗻𝗮𝘁𝗮𝗹 𝗰𝗮𝗿𝗲—cast your vote and share your insights on what you think will drive the biggest impact in the next 5 years? (other answers - we are very happy for your comments 🙏) #predictiveanalytics #preeclampsia #neonatalcare #maternalcare

Yesterday, our CEO Thorsten Waloschek delivered an impactful presentation at the DELPHI Conference, addressing the critical disconnect between data collection and clinical innovation. He emphasized the urgent need for all of us to bridge the gap, ensuring that valuable data not only exists but is accessible and actionable to drive medical advancements. Our call to action is clear: it’s up to each of us to contribute to a future where data is readily available and used in ways that truly benefit patients, providing the care and outcomes they deserve. #datacollection #innovation #DELPHI2024

🚨  𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 𝗡𝗲𝗼𝗣𝗿𝗲𝗱𝗶𝗫!  🚨 We are thrilled to announce that NeoPrediX will be exhibiting at the DELPHI Conference from September 23-25 in Fort Lauderdale, FL! Join us for a session with our CEO, Thorsten Waloschek, as he presents: Predictive Analytics within Clinical Decision Support Software: The Disconnect between Data Collection, Innovation, and Clinical Application. Don't miss this opportunity to explore how predictive analytics can bridge gaps and enhance clinical decision-making in neonatal care. Let's push the boundaries of innovation together! If you haven't done so already, click the link to register! 👇 #PredictiveAnalytics #ClinicalInnovation #DELPHI2024 #NeoPrediX